Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study

Abstract

CGM-adapted insulin regimen improves glycemic control without increasing hypoglycemic events in hemodialyzed diabetic patients. CGM could be a useful tool for the management of insulin therapy in these patients. These results need to be confirmed by long-term studies with larger sample sizes.